Imbruvica

Active Ingredient(s): Ibrutinib
FDA Approved: * November 13, 2013
Pharm Company: * PHARMACYCLICS
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Imbruvica Overview

Ibrutinib (Imbruvica) is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia. Ibrutinib was created by scientists at Celera Genomics as a tool compound for studying BTK function, then developed by Pharmacyclics up to Phase II, then partnered with Johnson & Johnson. Pharmacyclics was a...

Read more Imbruvica Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ibrutinib

Recent Imbruvica Forums: RSS Feed

side effects with imbruvica

I have CLL/SLL with 11q deletion, recently I have been having several problems and cannot find the right information on this drug I am on called IMBRUVICA or IMBRUTINIB, my issues are side effects related such as liver issues and skin rashes of which in the past I have only had skin problems in the past but now my skin rashes are getting worse and with just having an MRI of my pelvis they found I have problems with my liver ie; damage suggesting blood backing up without any bleeding of the veins. any help greatly appreciated. ## How long have you been taking it? Cancer medications are notorious for causing side effects, according to the FDA and the NIH, you may also experience nausea, dizziness, and hair loss. Are you on any other medications? ## I am on a myriad of meds ie; back pain f...

Updated
Side effects of joint and bone pain

I am going into my fourth month and the side effects of jo my fourth month and the side effects joint and bone pain are now a daily occurrence. I take 3 capsules daily and I am curious if a reduction to 2 a day would alleviate this side effect. Also other side effects are light headiness, skin breakouts, slight bruising and fatigue. I am an 83 yr old male who for most of my life has not or does not take any drugs except Imbruvica for SLL. ## Such side effects are normal with this class of medications, according to the FDA and you should continue taking the amount your doctor has instructed you to take. You may also experience diarrhea, and anemia. Are you on any other medications or treatments? I hope you experience the best outcome possible!

Updated

Possible Dosages for this and Related Drugs:

Ibrutinib
  • Capsule: 140 Mg., 140mg, 70mg
  • Tablet: 140mg, 280mg, 420mg, 560mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Imbruvica: (6 results)

Sorted by National Drug Code
  • 57962-014 Imbruvica 140 mg Oral Tablet, Film Coated by Pharmacyclics LLC
  • 57962-070 Imbruvica 70 mg Oral Capsule by Pharmacyclics LLC
  • 57962-140 Imbruvica (Ibrutinib 140 mg) by Pharmacyclics, Inc
  • 57962-280 Imbruvica 280 mg Oral Tablet, Film Coated by Pharmacyclics LLC
  • 57962-420 Imbruvica 420 mg Oral Tablet, Film Coated by Pharmacyclics LLC
  • 57962-560 Imbruvica 560 mg Oral Tablet, Film Coated by Pharmacyclics LLC

Other drugs which contain Ibrutinib or a similar ingredient: (1 result)

Related Imbruvica Topics:

side effects with imbruvica
I have CLL/SLL with 11q deletion, recently I have been having several problems and cannot find the right information on ... 4 replies






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 26 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA